162 results

  • 3HP regimen soon to be accessible in Malawi

    Thursday 31 October 2019

    KNCV Tuberculosis Foundation Malawi welcomes the substantial reduction in the price of the anti-tuberculosis drug rifapentine, announced today at the Union World Conference on Lung Health in India. “For people […]

  • Important price reduction improves access to TB prevention

    Thursday 31 October 2019

    KNCV Tuberculosis Foundation welcomes the announcement of a substantial reduction in the price of an anti-tuberculosis medicine through the support of Unitaid and the Global Fund, in partnership with the […]

  • Innovative TB treatment support project kicks off in the Philippines

    Wednesday 25 September 2019

    ASCENT aims to assist patients succeed in treatment using digital adherence technology. On World Lung Day, the innovative TB treatment support project ASCENT kicks off in the Philippines, making the […]

  • Antacid helps tuberculosis bacteria to survive

    Sunday 1 September 2019

    In 2017, some 10 million people suffered from tuberculosis and 1.6 million died of the disease. One reason why infection with Mycobacterium tuberculosis is so difficult to treat is that […]

  • 7th European Advanced Course in Clinical Tuberculosis

    Thursday 22 August 2019

    7th European Advanced Course in Clinical Tuberculosis Rotterdam, the Netherlands,  11-13 November 2019 Venue: LantarenVenster, Otto Reuchlinweg 996, 3072 MD Rotterdam, the Netherlands The 7th European Advanced Course in Clinical […]

  • FDA approval of BPaL regimen an important breakthrough in TB control

    Wednesday 14 August 2019

    The US Food & Drug Administration (FDA) today approved pretomanid for the treatment of highly drug-resistant forms of tuberculosis (TB) in a combination regimen known as BPaL. This regimen was […]

  • ASCENT: Empowering patients through digital technology

    Tuesday 23 July 2019

    GENEVA/THE HAGUE, The next three and a half years, KNCV Tuberculosis Foundation will lead the innovative ASCENT project, which stands for Adherence Support Coalition to End TB. This brand new […]

  • Call to Action for awareness on AMR

    Thursday 20 June 2019

    KNCV Tuberculosis Foundation is one of the civil society organizations that signs the Call to Action for awareness on antimicrobial resistance (AMR) in the Netherlands. Kitty van Weezenbeek, director of […]

  • Wolfheze Workshops 2019: inspiring knowledge exchange & concrete steps forward

    Tuesday 28 May 2019

    KNCV Tuberculosis Foundations can look back at an inspiring edition of the Wolfheze Workshops 2019 (15-17 May). In Scheveningen 160 TB experts from over 40 countries from Western Europe, Eastern […]

  • Unique gathering of TB and HIV experts in Scheveningen

    Wednesday 15 May 2019

    Biennial Wolfheze Workshops focuses on alarming tandem of infectious diseases THE HAGUE, 15 May 2019 International experts in the field of tuberculosis (TB) and HIV control meet today in Scheveningen […]